All stock lists
Visteon Corporation (NASDAQ:VC)
US · Delayed Price · Currency is USD
Consumer Cyclical · Auto - Parts
$80.90-$0.40 (-0.49%)
Market cap
$2.00B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 5, 2010
Website
VC analyst forecast
VC analyst consensus
Moderate Buy6 ratings
Buy 6 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
VC 12-month price target
$118.50+46.6% upsideaverage of 4 firms
$132.00High
$96.00Low
Best analysts covering VC
- TD Cowen100%success rate · +1.6% avg return · 1 call
- Barclays86%success rate · +16.8% avg return · 7 calls
- Wells Fargo70%success rate · +6.6% avg return · 23 calls
- Goldman Sachs67%success rate · +12.4% avg return · 6 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
VC analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-28 |
| TD Cowen | Buy | $131.00 | +71.5% | Reiterated | 2026-10-23 | |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-10-23 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-10-23 |
| UBS | Buy | $96.00 | +27.5% | Reiterated | 2026-10-23 | |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-10-06 |
| — | Wolfe Research | Peer Perform | — | — | Downgraded | 2026-07-28 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-07-24 |
| Deutsche Bank | Buy | $132.00 | +25.5% | Reiterated | 2026-07-09 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-06-29 |
| Deutsche Bank | Buy | $133.00 | +31.2% | Reiterated | 2026-06-26 | |
| — | Baird | Neutral | — | — | Downgraded | 2026-06-26 |
| Morgan Stanley | Equal Weight | $115.00 | +0.0% | Reiterated | 2026-06-26 | |
| — | JP Morgan | Overweight | — | — | Upgraded | 2026-06-22 |
| — | Barclays | Overweight | — | — | Upgraded | 2026-06-22 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-04-27 |
| — | Wolfe Research | Outperform | — | — | Upgraded | 2026-04-27 |
| — | UBS | Buy | — | — | Reiterated | 2026-04-24 |
| — | Baird | Outperform | — | — | Reiterated | 2026-04-24 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-04-23 |
| — | Wolfe Research | Peer Perform | — | — | Downgraded | 2026-01-12 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-12-08 |
VC earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-19 | $2.08 | $2.96 | $920.1M | $948.0M |
| 2026-04-23 | $1.96 | $1.65 | $897.8M | $954.0M |
| 2026-07-23 | $2.21 | $1.91 | $955.8M | $960.0M |
| 2026-10-22 | $2.28 | $0.19 | $936.4M | $970.0M |
| 2027-02-18Upcoming | $2.32 | — | $944.4M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
